Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: A Gynecologic Oncology Group study

L HESS; R BARAKAT; C TIAN; R OZOLS; D ALBERTS

doi:10.1016/j.ygyno.2007.06.010

Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.06.010 ◽

2007 ◽

Vol 107 (2) ◽

pp. 260-265 ◽

Cited By ~ 53

Author(s):

L HESS ◽

R BARAKAT ◽

C TIAN ◽

R OZOLS ◽

D ALBERTS

Keyword(s):

Prognostic Factor ◽

Ovarian Carcinoma ◽

Weight Change ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Potential Prognostic Factor

Get full-text (via PubEx)

Response to Dr. Markman's letter “Re: ‘Randomized phase III trial of three versus six cycles of carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group Study’”

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.007 ◽

2007 ◽

Vol 105 (1) ◽

pp. 280-281

Author(s):

J BELL

Keyword(s):

Ovarian Carcinoma ◽

Early Stage ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Get full-text (via PubEx)

Re: “Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study”

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.006 ◽

2007 ◽

Vol 105 (1) ◽

pp. 279-280 ◽

Cited By ~ 3

Author(s):

M MARKMAN

Keyword(s):

Ovarian Carcinoma ◽

Early Stage ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Get full-text (via PubEx)

Randomized trial of intraperitoneal chronic phosphate therapy versus observation following negative second-look laparotomy for stage III ovarian carcinoma: a gynecologic oncology group study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(02)03170-x ◽

2002 ◽

Vol 54 (2) ◽

pp. 66

Author(s):

M.A Varia ◽

F.B Stehman ◽

B.N Bundy ◽

J Benda ◽

D.L Clarke-Pearson ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Randomized Trial ◽

Gynecologic Oncology ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Second Look

Get full-text (via PubEx)

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.06.013 ◽

2006 ◽

Vol 102 (3) ◽

pp. 432-439 ◽

Cited By ~ 177

Author(s):

Jeffrey Bell ◽

Mark F. Brady ◽

Robert C. Young ◽

Janice Lage ◽

Joan L. Walker ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Early Stage ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Get full-text (via PubEx)

Whole Abdominal Radiotherapy in the Adjuvant Treatment of Patients With Stage III and IV Endometrial Cancer: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70597-6 ◽

2006 ◽

Vol 2006 ◽

pp. 449-452

Author(s):

S.D. Yamada

Keyword(s):

Endometrial Cancer ◽

Adjuvant Treatment ◽

Gynecologic Oncology ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Abdominal Radiotherapy

Get full-text (via PubEx)

Therapy of Stage III (Optimal) Epithelial Carcinoma of the Ovary with Melphalan or Melphalan Plus Corynebacterium Parvum (A Gynecologic Oncology Group Study)

Obstetrical & Gynecological Survey ◽

10.1097/00006254-198742020-00025 ◽

1987 ◽

Vol 42 (2) ◽

pp. 128-130

Author(s):

S. GALL ◽

B. BUNDY ◽

J. BEECHAM ◽

C. WHITNEY ◽

H. HOMESLEY ◽

...

Keyword(s):

Gynecologic Oncology ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Corynebacterium Parvum ◽

Carcinoma Of The Ovary

Get full-text (via PubEx)

The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1)

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.02.010 ◽

2019 ◽

Vol 153 (2) ◽

pp. 312-319

Author(s):

Ryusuke Murakami ◽

Noriomi Matsumura ◽

Hirofumi Michimae ◽

Hiroshi Tanabe ◽

Mayu Yunokawa ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

High Grade ◽

Oncology Group ◽

Oncology Group Study ◽

Mesenchymal Transition ◽

Serous Ovarian Carcinoma ◽

Dose Dense ◽

Taxane Chemotherapy

Get full-text (via PubEx)

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.05.029 ◽

2018 ◽

Vol 150 (2) ◽

pp. 247-252 ◽

Cited By ~ 18

Author(s):

John K. Chan ◽

William Brady ◽

Bradley J. Monk ◽

Jubilee Brown ◽

Mark S. Shahin ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Phase Ii ◽

Clear Cell ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Clear Cell Ovarian Carcinoma

Get full-text (via PubEx)

Brain metastases from epithelial ovarian carcinoma: Evaluation of prognosis and managements — A Taiwanese Gynecologic Oncology Group (TGOG) Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.12.438 ◽

2012 ◽

Vol 125 (1) ◽

pp. 37-41 ◽

Cited By ~ 9

Author(s):

Ying-Cheng Chiang ◽

Jian-Tai Qiu ◽

Chih-Long Chang ◽

Peng-Hui Wang ◽

Chih-Ming Ho ◽

...

Keyword(s):

Brain Metastases ◽

Ovarian Carcinoma ◽

Gynecologic Oncology ◽

Epithelial Ovarian Carcinoma ◽

Gynecologic Oncology Group ◽

Oncology Group

Get full-text (via PubEx)

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.11.013 ◽

2006 ◽

Vol 100 (1) ◽

pp. 27-32 ◽

Cited By ~ 227

Author(s):

Joan L. Walker ◽

Deborah K. Armstrong ◽

Helen Q. Huang ◽

Jeffrey Fowler ◽

Kenneth Webster ◽

...

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Get full-text (via PubEx)